Appraisal of the World Health Organization classification of lung tumours
- PMID: 7370873
- PMCID: PMC1801636
Appraisal of the World Health Organization classification of lung tumours
Abstract
The 1967 World Health Organization (WHO) classification of the histologic types of lung tumours has been examined in relation to 303 tumours of patients admitted to a national trial of the treatment of lung cancer. In 63 instances (20%) there was disagreement between the diagnoses of the local pathologist and the reference pathologist. The slides for these 63 tumours were reviewed by two other pathologists, and the slides for 60 tumours for which there was agreement between the local and reference pathologists were reviewed by one of the other pathologists. The main disagreement was in the diagnosis of epidermoid (squamous) tumours. It is apparent that many pathologists do not adhere to the strict criterion of the presence of keratinization or intercellular prickles or both for the diagnosis of epidermoid carcinoma. In addition, there was substantial variation in the use of subtypes within the WHO classification. Use of the revised classification proposed by the WHO would have removed a small amount of the variation from these findings but would not have affected the main discrepancy. Stricter attention to the definition of types is required for a uniform approach to the histologic classification of lung tumours.
Similar articles
-
The World Health Organization. Histological typing of lung tumours.Neoplasma. 1982;29(1):111-23. Neoplasma. 1982. PMID: 6280081
-
Pathologic review of the Mayo Lung Project cancers [corrected]. Is there a case for misdiagnosis or overdiagnosis of lung carcinoma in the screened group?Cancer. 2002 Dec 1;95(11):2361-5. doi: 10.1002/cncr.10930. Cancer. 2002. PMID: 12436443
-
Histological typing of lung cancer. Application of the World Health Organization classification to 479 cases.Acta Pathol Microbiol Scand A. 1976 Nov;84(6):529-37. Acta Pathol Microbiol Scand A. 1976. PMID: 187006
-
[Classification and pathogenesis of lung carcinoma].Rev Prat. 2003 Apr 1;53(7):714-20. Rev Prat. 2003. PMID: 12879793 Review. French.
-
[Classification of broncho-pulmonary cancers (WHO 1999)].Rev Mal Respir. 2002 Sep;19(4):455-66. Rev Mal Respir. 2002. PMID: 12417862 Review. French.
Cited by
-
Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer.J Thorac Oncol. 2014 Feb;9(2):170-8. doi: 10.1097/JTO.0000000000000066. J Thorac Oncol. 2014. PMID: 24419413 Free PMC article.
-
Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway.Oncotarget. 2016 Jun 28;7(26):40377-40386. doi: 10.18632/oncotarget.9750. Oncotarget. 2016. PMID: 27777384 Free PMC article.
-
Collagen triple helix repeat containing 1 (Cthrc1) is an independently prognostic biomarker of non-small cell lung cancers with cigarette smoke.Tumour Biol. 2014 Nov;35(11):11677-83. doi: 10.1007/s13277-014-2449-0. Epub 2014 Aug 21. Tumour Biol. 2014. PMID: 25139095
-
NDRG1 attenuates epithelial-mesenchymal transition of nasopharyngeal cancer cells via blocking Smad2 signaling.Biochim Biophys Acta. 2015 Sep;1852(9):1876-86. doi: 10.1016/j.bbadis.2015.06.009. Epub 2015 Jun 10. Biochim Biophys Acta. 2015. PMID: 26071641 Free PMC article.
-
Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer.ACS Omega. 2020 Aug 20;5(34):21550-21560. doi: 10.1021/acsomega.0c02165. eCollection 2020 Sep 1. ACS Omega. 2020. PMID: 32905276 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical